Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tiotropium Respimat once-daily evening versus twice-daily dosing in moderate persistent asthma
2012-001873-10Phase 2Completed
- Sponsor
- Boehringer Ingelheim
- Start
- Jul 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of tiotropium in asthma (2 arms), sponsored by Boehringer Ingelheim. Primary endpoint: Forced expiratory volume in one second (FEV1). Started Jul 2012; status: completed.
02
Drugs
tiotropium
03
Conditions
asthma
Beyond the preview
Go deeper on 2012-001873-10.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-001873-10.